The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats

African Journal of Biotechnology

Volumn 9, Issue 31, 2010, Pages 5004-5012

  Abdollahi, M ^a   Zuki, A B Z ^a   Goh, Y M ^a   Rezaeizadeh, A ^a   Noordin, M M ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Diabetes; Liver; Momordica charantia; Neonatal rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLIBENCLAMIDE; GLUCOSE; INSULIN; MALONALDEHYDE; MOMORDICA CHARANTIA EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FRUIT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIVER HISTOLOGY; MICROSCOPY; MOMORDICA CHARANTIA; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES;

MOMORDICA CHARANTIA; RATTUS;

EID: 77956118312     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Abdelsattarelbatran S, Elgengaihi S, Elshabrawy O (2006). Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic. rats. J. Ethnopharmacol. 108: 236-242.
2. Ahmad N, Hassan MR, Halder H, Bennoor KS (1999). Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Med. Res. Counc. Bull. 25: 11-13.
3. Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J (1998). Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res. Clin. Pract. 40: 145-151.
4. Ahmed FN, Naqvi FN, Shafiq F (2006). Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus. Ann. NY. Acad. Sci. 1084: 481-489.
5. Bastaki S (2005). Review Diabetes mellitus and its treatment. Int. J. Diabetes Metabol. 13: 111-134.
6. Baynes JW, Thorpe SR (1999). Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48: 1-9.
7. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, Okyar A (2004). Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol. Pharm. Bull. 27: 694-698.
8. Chaturvedi P, George S, Milinganyo M, Tripathi YB (2004). Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother. Res. 18: 954-956.
9. Chen Q, Chan LLY, Li ETS (2003). Bitter Melon (Momordica charantia) Reduces Adiposity, Lowers Serum Insulin and Normalizes Glucose Tolerance in Rats Fed a High Fat Diet. J. Nutr. 133: 1088-1093.
10. Fernandes NPC, Lagishetty CV, Panda VS, Naik SR (2007). An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement. Altern. Med. 7: 29.
11. Garau C, Singh J, Cummings E (2003). Beneficial effect and mechanism of action of Momordica Charantia in the treatment of diabetes mellitus: a mini review. Int. J. Diabetes Metabol. 11: 46-55.
12. Goren HJ, Kulkarni RN, Kahn CR (2004). P Glucose Homeostasis Tissue Transcript Content of Insulin Signaling Intermediates in Four Inbred of Mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinol.145:3307-3332.
13. Grover JK, Yadav SP (2004). Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol. 93: 123-132.
14. Guven A, Yavuz O, Cam M, Ercan F, Bukan N, Comunoglu C, Gokce F (2006). Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta. Histochemica, 108: 85-93.
15. Hribal ML, D'Alfonso R, Giovannone B, Lauro D, Liu YY, Borboni P, Federici M, Lauro R, Sesti G (2001). The sulfonylurea glimepiride regulates intracellular routing of the insulin-receptor complexes through their interaction with specific protein kinase C isoforms. Mol. Pharmacol. 59: 322-330.
16. Krawinkel MB, Keding GB (2006). Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia. Nutr. Rev. 64: 331-337.
17. Kim JD, Kang SM, Seo BI, Choi HY, Choi HS, Ku SK (2006). Antidiabetic activity of SMK001, a poly herbal formula in streptozotocin induced diabetic rats: therapeutic study. Biol. Pharm. Bull. 29: 477-482.
18. Mahboob M, Rahman MF, Grover P (2005). Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore. Med. J. 46: 322-324.
19. Mahomoodally MF, Gurib-Fakim A, Subratty AH (2007). Effect of exogenous ATP on Momordica charantia Linn. (Cucurbitaceae) induced inhibition of D-glucose, L-tyrosine and fluid transport across rat everted intestinal sacs in vitro. J. Ethnopharmacol. 110: 257-263.
20. McCarty MF (2004). Does bitter melon contain an activator of AMP activated kinase? Med. Hypotheses, 63: 340-343.
21. Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I (2001). Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J. Nutr. Sci. Vitaminol. 47: 340-344.
22. Liu C, Yen M, Tsang S, Gan K, Hsu H, Lin C (2010). Antioxidant triterpenoids from the stems of Momordica charantia. Food Chem. Toxicol. 118: 751-756.
23. Li L, Yi Z, Seno M, Kojima I (2004). Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocintreated rats. Diabetes, 53: 608-615.
24. Lupi R, Del Prato S (2008). B-cell apoptosis in type 2 diabetes: quantitative and functional consequences. Diabetes Metab. 34: 56-64.
25. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358.
26. Packer L, Rossen P, Tritschter HJ, King GL, Azzi (2000). Antioxidants in diabetes management. New York: Macel Dekker, Inc.
27. Portha B, Movassat J, Cuzin-Tourrel C, Bailbe D, Giroix MH, Serradas P, Dolz M, Kergoat, M (2007). Neonatally streptozotocin-induced (n-STZ) diabetic rats: A family of type 2 diabetes models. In E. Shafrir (Ed.) Animal Models of Diabetes: Frontiers in Research. New York. CRC Press. pp. 223-250.
28. Sathishsekar D, Subramanian S (2005). Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol. Pharm. Bull. 28: 978-983.
29. Sakamoto K, Yonoki Y, Fujioka T, Matsumura M, Mitsuta Y, Sano M, Saito M,Nakahara T,Ishii K (2006). Disappearance of glibenclamideinduced hypoglycemia in Wistar-Kyoto rats. Biol. Pharm. Bull. 29: 574-576.
30. Semiz A, Sen A (2007). Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. Afr. J. Med. Med Sci. 6: 273-277.
31. Shih C, Lin C, Lin W, Wu J (2009). Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructosefed rats. J. Ethnopharmacol. 123: 82-90.
32. Shulman GI (2000). Cellular mechanisms of insulin resistance. J. Clin. Invest. 106: 171-176.
33. Sitasawad SL, Shewade Y, Bhonde R (2000). Role of bittergourd fruit juice in STZ-induced diabetic state in vivo and in vitro. J. Ethnopharmacol. 73: 71-79.
34. Sridhar MG, Vinayagamoorthi R, Arul Suyambunathan V, Bobby Z, Selvaraj N (2008). Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br. J. Nutr. 99: 806-812.
35. Sun F, Hamagawa E, Tsutsui C, Sakaguchi N, Kakuta Y, Tokumaru S, Kojo S (2003). Evaluation of oxidative stress during apoptosis and necrosis caused by -galactosamine in rat liver. Biochem. Pharmacol. 65: 101-107.
36. Traverso N, Menini S, Maineri EP, Patriarca S, Odetti P, Cottalasso D, Marinari U, Pronzato M (2004). Malondialdehyde, a Lipoperoxidation-Derived Aldehyde, Can Bring About Secondary Oxidative Damage To Proteins. J. Gerontol. Biol. Med. Sci. 59: 890-895.
37. Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK (2003). Antihyperglycemic effects of three extracts from Momordica charantia. J. Ethnopharmacol. 88: 107-111.
38. Vitaglione P, Morisco F, Caporaso N, and Fogliano V (2004). Dietary antioxidant compounds and liver health. Crit. Rev. Food Sci. Nutr. 44: 575-586.
39. Wendel AA, Purushotham A, Liu L, Belury MA (2008). Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J. Lipid Res. 49: 98-106.
40. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS (1986). Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 17: 277-282.
41. Wu S, Ng L (2008). Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) in Taiwan. LWT-Food Sci. Technol. 41: 323-330.
42. Zhang M, Lv X, Li J, Xu Z, Chen L (2008). The characterization of highfat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Int. J. Exp. Diabetes Res. 7(4): 45.